Project Grant HT94252510371
Award Date
6/15/25
Completion Date
6/14/28
Dollars Obligated
$4.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Andover, MA 01810, USA
Similar Awards
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $466,970.00 to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, to conduct research toward ultra-long-term intra-articular delivery of disease-modifying biologics to reduce the progression of post-traumatic osteoarthritis. The award period is from February 15, 2025 to February 14, 2027....
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,000,000.00 in funding to Tekhona Inc., a for-profit S corporation, to develop intra-articular immunoregulatory microparticles for inducing systemic remission in rheumatoid arthritis. The 2-year research project, with an award date of September 15, 2023 and an ultimate completion date of September 14, 2025, aims to transform healthcare for Service...
The Department of the Army Medical Command, through its Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,999,583 project grant to IRR Inc. located in Santa Barbara, CA. The funding supports an early-stage proof-of-concept study of a fixed-dose combination therapy in a high-fidelity porcine model of severe polytrauma. The 2-year project, running from July 1, 2025 to June 30, 2027, aims to explore innovative approaches to disease prevention, diagnosis,...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $442,750.00 to the University of California, Davis to "DETERMINE THE ROLE OF HISTONE LACTYLATION IN POSTTRAUMATIC OSTEOARTHRITIS AND ARTHRITIC PAIN". The award period runs from Feb 1, 2025 to Jan 31, 2027. The Military Medical Research and Development program supports advanced biomedical research initiatives focused on...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $749,343 federal Project Grant award, with a performance period from August 1, 2025 to July 31, 2027, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by New York University School of Medicine to develop a peptide treatment for cartilage injuries and post-traumatic osteoarthritis. The university has a history of performing specialized medical and scientific research services for various...
This Project Grant award from the Department of the Army Medical Command provides $723,973 to New York University under the Military Medical Research and Development program (CFDA 12.420) to support research on treating oral cancer pain with LRP1 agonists. The three-year award beginning September 30, 2022 will fund research into investigating medical solutions for battlefield injuries through the development of innovative approaches for managing oral cancer pain. The Military Medical Research...
The Department of the Army Medical Command awarded a $1,509,972 project grant to the Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from September 2022 through September 2025 to assess neuroinflammation in chronic pain using non-invasive microstructural imaging techniques. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $322,800 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by Mayo Clinic to investigate the role of osteoprotegerin as a mediator of post-traumatic osteoarthritis through a novel etiopathophysiological mechanism. The research project aims to advance scientific understanding and develop new treatments for this condition, which is particularly relevant for...